Pseudovirus Service
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening
people's health around the world. The virus had already arrived in numerous areas of the world due to its potent
transmissibility. As the virus continues its global spread, understanding of SARS-CoV-2 mechanism is critical for
drug discovery and vaccine development. As a leading company, Creative Biogene provides reliable and high-quality
pseudovirus service in support of SARS-CoV-2 studies. We will make our own contribution to fight against COVID-19
disease.

COVID-19 crises have led to enormous worldwide efforts to urgently develop drug treatments and vaccines effective
against SARS-CoV-2. Due to the high infectivity and pathogenicity, SARS-CoV-2 should be dealt with in biosafety
level 3 laboratories, which limit the anti-viral measure development. Pseudoviruses have the essential components
for cell entry and viral infection, but lack of nucleic acid and lose self-replication ability. They have been
regarded as the effective virological tools due to their safety and versatility, especially for appearing and
re-appearing viruses. At present, researchers use pseudoviruses to mimic SARS-CoV-2 virus for further studies.
SARS-CoV-2 has four main structural proteins. The S protein is one of the key components to bind the receptor and
mediate membrane fusion and virus entry. It is a main target for neutralizing antibodies and vaccine design. With
extensive experience in pseudoviruses, Creative Biogene provides pseudovirus service based on lentiviral and VSV
systems for SARS-CoV-2 studies. We have developed a pseudotype system with S protein of SARS-CoV-2 to support virus
entry study in BSL2 facilities. Pseudovirus-based neutralization assays are provided for detecting neutralizing
antibodies. In addition, multiple related pseudovirus products and custom services are also available.
The following is the details of pseudoviruses provided by Creative Biogene:
| Cat. No. |
Product Name |
Price |
| CoV-001 |
SARS-CoV-2 S Pseudotyped GFP Lentivirus |
Inquiry |
| CoV-001a |
SARS-CoV-2 S Pseudotyped GFP Lentivirus (Alpha strain S) |
Inquiry |
| CoV-001b |
SARS-CoV-2 S Pseudotyped GFP Lentivirus (Beta strain S) |
Inquiry |
| CoV-001d |
SARS-CoV-2 S Pseudotyped GFP Lentivirus (Delta strain S) |
Inquiry |
| CoV-001o |
SARS-CoV-2 S Pseudotyped GFP Lentivirus (Omicron strain S) |
Inquiry |
| CoV-002 |
SARS-CoV-2 S Pseudotyped Luciferase Lentivirus |
Inquiry |
| CoV-002a |
SARS-CoV-2 S Pseudotyped Luciferase Lentivirus (Alpha strain S) |
Inquiry |
| CoV-002b |
SARS-CoV-2 S Pseudotyped Luciferase Lentivirus (Beta strain S) |
Inquiry |
| CoV-002d |
SARS-CoV-2 S Pseudotyped Luciferase Lentivirus (Delta strain S) |
Inquiry |
| CoV-002o |
SARS-CoV-2 S Pseudotyped Luciferase Lentivirus (Omicron strain S) |
Inquiry |
| CoV-009 |
SARS-CoV-2 S Pseudotyped mCherry Lentivirus |
Inquiry |
| CoV-010 |
SARS-CoV2 S-ΔG-mCherry Pseudotyped VSV |
Inquiry |
| CoV-012 |
SARS-CoV2 S-ΔG-GFP Pseudotyped VSV |
Inquiry |
| CoV-013 |
SARS-CoV2 S-ΔG-Luciferase Pseudotyped VSV |
Inquiry |
| CoV-014 |
SARS-CoV2 S-ΔG Pseudotyped VSV |
Inquiry
|
| CoV-015 |
SARS-CoV-2 S Pseudotyped GFP-Luciferase Lentivirus |
Inquiry |
| CoV-016 |
SARS-CoV-2 S D614G Pseudotyped GFP-Luciferase Lentivirus |
Inquiry |
| CoV-017 |
SARS-CoV-2 S D614G Pseudotyped mCherry-Luciferase Lentivirus |
Inquiry |
| CoV-018 |
SARS-CoV-2 S E484K/N501Y Pseudotyped GFP Lentivirus |
Inquiry |
| CoV-019 |
SARS-CoV-2 S E484K/N501Y Pseudotyped Luciferase Lentivirus |
Inquiry |
| CoV-020 |
SARS-CoV-2 S N501Y Pseudotyped GFP Lentivirus |
Inquiry |
| CoV-021 |
SARS-CoV-2 S N501Y Pseudotyped GFP-Luciferase Lentivirus |
Inquiry |
Why Choose Creative Biogene
- Mature and excellent platform
- Years of experience in pseudovirus
- Rapid turnaround time
- Competitive price
- Customized pseudovirus products and services
Together with global researchers and scientists, Creative Biogene is dedicating to provide pseudovirus service with
high quality in support of SARS-CoV-2 research. More pseudoviruses are available at Creative Biogene. If you are
interested in our pseudovirus service or have any additional requirements, please feel free to contact us.
In order to better support SARS-CoV-2 studies, related virus particles are provided in the table below:
| Cat.No. |
Product Name |
| AD00537Z |
Human ACE2 adenoviral particles |
| LV04219L |
human ACE2 (NM_021804) lentivirus particles |
| AD16629Z |
Human TMPRSS2 adenoviral particles |
| LV28259L |
human TMPRSS2 (NM_005656) lentivirus particles |
| LV28260L |
human TMPRSS2 (NM_001135099) lentivirus particles |
References:
- Nie, J., Li, Q., Wu, J., Zhao, C., Hao, H., Liu, H., Zhang, L., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X.,
Sun, Q., Liu, J., Fan, C., Huang, W., Xu, M., Wang, Y. (2020). Establishment and validation of a pseudovirus
neutralization assay for SARS-CoV-2. Emerging Microbes & Infections, 9(1), 680–686.
- Walls, A.C., Park, Y.J., Tortorici, M.A., Wall, A., McGuire, A.T., Veesler, D. (2020) Structure, Function,
and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 181(2):281-292.e6.
- Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., Xiang, Z., Mu, Z.,
Chen, X., Chen, J., Hu, K., Jin, Q., Wang, J.,Qian, Z. (2020). Characterization of spike glycoprotein of
SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications,
11(1).
* For research use only. Not intended for any clinical use.